News

Christopher Good, Director of Cell and Gene Therapy Logistics at Biocair, will explore ongoing material sourcing challenges for organisations moving from development to clinical and commercial manufacturing in an upcoming webinar taking place on 12 March 2020. Critical considerations in...

Bactiguard Holding AB has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on 4 February 2020. All conditions precedent have been fulfilled and the first part of the total consideration, consisting of...

Gilead Sciences Inc (GILD.O) said it would buy Forty Seven Inc (FTSV.O) for $4.9 billion in cash, adding an experimental treatment that targets blood cancer to its portfolio of oncology drugs. Shares of Forty Seven jumped 62%, trading slightly below...

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced U.S. FDA clearance of its Basal-IQ™ technology as an interoperable automated glycemic controller (iAGC). This is the second system to receive iAGC designation by the FDA,...

Boston-based Laboratory-as-a-Service (LaaS) leader, SmartLabs, announced a national expansion with the addition of 80,000 square feet in South San Francisco, California. Building upon its continued success in Massachusetts, SmartLabs’s new San Francisco laboratories will deliver high quality, turnkey R&D...

Altasciences, a mid-size CRO specializing in a flexible, innovative approach to providing comprehensive early stage drug development from lead candidate selection to proof of concept, announced that it has acquired Alliance Contract Pharma. This acquisition adds small molecule contract...

Samsung Biologics and STCube announced a strategic development and manufacturing service agreement for STT-003 antibody, an anti-cancer drug candidate. Under the agreement, Samsung Biologics will offer a wide range of services from cell line development, process development, manufacturing of non-clinical...